NN
Nicola Neeladri
About Nicola Neeladri
Data last updated:
Nicola Neeladri is a Director at Bal Pharma Limited (since 2020), Director at Mro-Tek Networks Limited (since 2020) and Additional Director at Bluetech Design Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Information Technology and Engineering. The 4 current companies with reported revenue have a combined latest revenue of ₹358 Cr; the largest is Bal Pharma Limited at ₹305 Cr (FY 2025). Earlier, Nicola Neeladri was a Director at Life Science Tech Kvalito India Private Limited (2024–2025) and Director at Ra Chem Pharma Limited (2020) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bal Pharma Limited L85110KA1987PLC008368 | Director | 23 May 2020 | 1987 | ₹305 Cr (FY 2025) | Active |
 Mro-Tek Networks Limited L28112KA1984PLC005873 | Director | 15 Jun 2020 | 1984 | ₹51.37 Cr (FY 2025) | Active |
 Bluetech Design Private Limited U74999KA2017FTC106070 | Additional Director | 22 Dec 2025 | 2017 | ₹95.3 Lakh (FY 2025) | Active |
 Isg Novasoft Technologies Limited U72900KA2003PLC050528 | Director | 01 Apr 2020 | 2003 | ₹6.6 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Life Science Tech Kvalito India Private Limited U70200KA2024FTC188977 | Director | 26 May 2024 | 2024 | Active | |
 Ra Chem Pharma Limited U24110TG1996PLC022816 | Director | 30 Jun 2020 | 1996 | ₹621 Cr (FY 2021) | Amalgamated |
 Opto Circuits (India) Limited L85110KA1992PLC013223 | Additional Director | 14 Feb 2020 | 1992 | ₹186 Cr (FY 2020) | Under Cirp |
| Red Sun Information Technologies Private Limited U72900KA2021PTC145762 | Director | 24 Mar 2021 | 2021 | Strike Off | |
| Red Sun Diamonds Impex Private Limited U36910KA2008PTC045351 | Director | 21 Feb 2008 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nicola Neeladri
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nicola Neeladri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nicola Neeladri
Nicola Neeladri currently holds 4 directorships: Bal Pharma Limited (Director, since 23 May 2020, revenue ₹305 Cr (FY 2025)); Mro-Tek Networks Limited (Director, since 15 Jun 2020, revenue ₹51.37 Cr (FY 2025)); Bluetech Design Private Limited (Additional Director, since 22 Dec 2025, revenue ₹95.3 Lakh (FY 2025)); Isg Novasoft Technologies Limited (Director, since 01 Apr 2020, revenue ₹6.6 Lakh (FY 2025)).
Nicola Neeladri was first appointed on 21 Feb 2008 as Director at Red Sun Diamonds Impex Private Limited. The most recent appointment on record is 22 Dec 2025 at Bluetech Design Private Limited.
The 4 current companies of Nicola Neeladri that report revenue have a combined latest revenue of ₹358 Cr: Bal Pharma Limited ₹305 Cr (FY 2025); Mro-Tek Networks Limited ₹51.37 Cr (FY 2025); Bluetech Design Private Limited ₹95.3 Lakh (FY 2025); Isg Novasoft Technologies Limited ₹6.6 Lakh (FY 2025).
Nicola Neeladri held 5 earlier board appointments: Life Science Tech Kvalito India Private Limited (Director, 26 May 2024 to 30 Jul 2025); Ra Chem Pharma Limited (Director, 30 Jun 2020 to 27 Oct 2020); Opto Circuits (India) Limited (Additional Director, 14 Feb 2020 to 30 Nov 2020); Red Sun Information Technologies Private Limited (Director, from 24 Mar 2021); Red Sun Diamonds Impex Private Limited (Director, from 21 Feb 2008).
The current boards of Nicola Neeladri's companies include Bheekamchand Mukesh (Bal Pharma Limited), Daddanala Venkat Bharath Bhushan (Bal Pharma Limited), Jatish Sheth (Bal Pharma Limited), Makkigadde Lakshminarayana Shreepada (Bal Pharma Limited), Ravindrakumar Kothari (Bal Pharma Limited), Shailesh Siroya (Bal Pharma Limited), among others.